Tag Archives: antibiotics resistance

The Key to Treating Pneumonia can be Found in Soil?

Can it really be that simple? Can the answer really be in the ground beneath our feet?

Source: Soil Science Society of America

Discovery of a gene cluster commonly found in soil-dwelling bacteria may be the key to treating anaerobic bacterial infections such as appendicitis and pneumonia. Researchers Jason B. Hedges and Prof. Dr. Katherine S. Ryan from the University of British Columbia have isolated the antibiotic compound azomycin from a biosynthetic gene cluster found in the bacterium Streptomyces cattleya.

With this information they believe it can lead to engineering bacteria to produce a new line of antibiotics.

What is a gene cluster?

The term gene cluster is moreso semantics to describe a group of genes that share a common phenomenon.

Originally, azomycin was isolated from a similar bacterium Streptomyces eurocidicus back in 1953 and became the blueprint to synthetic nitroimidazoles. 

“Nitroimidazoles are one of the most effective ways to treat anaerobic bacterial infections”,[1] Hedges writes in his 2019 study. The most commonly used nitroimidazole, metronidazole, is an antibiotic used to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis.[2] It is also on the World Health Organization’s List of Essential Medicines, the safest and most effective medicines needed in a health system.[3]

Figure 1: Molecular Structure of Nitroimidazole. Source: Sigma Aldrich

Despite its use in antibiotics for over 60 years, the incidence of nitroimidazole resistance in anaerobes remains low, making it an essential component of the antibiotic arsenal. [1,4]

Since the isolation of azomycin back in 1953, synthesis of nitroimidazoles were limited to synthetic routes, most commonly involving reactions of an imidazole with nitric acid and sulfuric acid. 

Using bioinformatics, however, in 2019 Hedges and Ryan were able identify a biosynthetic gene cluster in the same bacterium that makes penicillin,[5] Streptomyces cattleya. They were able to find that this gene cluster containing azomycin is widely distributed among soil-dwelling actinobacteria and proteobacteria.

Because of this they theorize that azomycin and other nitroimidazoles may be important factors in ecology.

What are bioinformatics?

Bioinformatics is the science of collecting and analyzing complex biological data such as genetic codes. As an interdisciplinary field of science, bioinformatics combines biology, computer science, information engineering, mathematics and statistics to analyze and interpret the biological data

In addition to the isolation of azomycin in a gene cluster, Hedges and Ryan were able to perform in vitro analysis in order to understand the enzymatic steps that take the primary protein L-arginine to become azomycin. 

Source: Washington Post

Their work opens the door to biocatalytic methods to synthesize azomycin and other nitroimidazoles. They believe this discovery can “lead to the possibility of engineering bacteria to produce nitroaromatic compounds”.[1]

In other words, this may lead to stronger antibiotics immune to drug resistance.

References

Hedges, J. B.; Ryan, K. S. In Vitro Reconstitution of the Biosynthetic Pathway to the Nitroimidazole Antibiotic Azomycin. Angewandte Chemie International Edition 201958 (34), 11647–11651.

The American Society of Health-System Pharmacists. Archived from the original on 6 September 2015. Retrieved 31 July 2015.

World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization

David I. Edwards, Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action, Journal of Antimicrobial Chemotherapy, Volume 31, Issue 1, January 1993, Pages 9–20, https://doi.org/10.1093/jac/31.1.9

Kahan, JS; Kahan, FM; Goegelman, R; Currie, SA; Jackson, M; Stapley, EO; Miller, TW; Miller, AK; Hendlin, D; Mochales, S; Hernandez, S; Woodruff, HB; Birnbaum, J (Jan 1979). “Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties”. The Journal of Antibiotics32 (1): 1–12

-Adrian Emata

Antibiotics found to kill bacteria in a new way!

 

Fig1.Antibiotics source

Antibiotic is the most powerful “weapon” to fight against bacterial infections. However, according to the World Health Organization, there are more than 700000 people die every year due to antibiotic resistance. On Feb 13th, 2020, Research team from the David Braley center for Antibiotic Discovery, University of McMaster posted an article on nature. Newly found corbomycin and complestatin would kill bacteria in a brand-new way. The discovery of these new groups of antibiotics would be the clinical candidate in the fight against antimicrobial resistance.

Fig2,Antibiotic resistance strategies in bacteria. source:Courtesy of E. Gullberg.

 

Antibiotics are the revolution of the pharmaceutical study in the 20th century. They are the most important type of antibacterial agent which either kills or inhibit the growth of bacterial cell walls. Alexander Fleming discovered modern antibiotic medicine – penicillin in 1928, which saved thousands of people’s life.

What does old antibiotics also bring you?

The enormous benefits of antibiotics also lead to new problems such as over-usage and resistance. Bacteria soon formed resistance toward these antibiotics and caused the ineffectiveness of the medicine. The resistance of antibiotics had become a new-rise problem. The World Health Organization announced: “serious threat is no longer a prediction for the future, it is happening right now in every region of the world and has the potential to affect anyone.”

Fig2.image of corbomycin

Fig2.image of corbomycin. source

The newly found corbomycin and complestatin have brand new way to attack bacteria. It is discovered from a glycopeptide family, and the new approach appears no significant resistance toward bacteria. “Antibiotics like penicillin kill bacteria by preventing the building of the wall, but the antibiotics that we found actually work by doing the opposite – they prevent the wall form being broken down. This is critical for cell to divide.” Said Beth Culp, a PhD candidate in biochemistry at McMaster.

Why do we know about these?

“We hypothesized that if the genes that made these antibiotics were different, maybe the way they killed the bacteria was also different”, Culp explained. The “unique approach” to kill bacteria is a new mechanism that is worthy of studying. Scientists might be able to find the new family of antibiotics which have a completely different way to attack bacteria. These new antibiotics will be the revolution of modern biochemistry which will be powerful to fight against antibiotic-resistant.

 

Scientists believed that the observation of corbomycin and complestatin would open the “new door” in the field of antibiotics. People will be able to investigate more antiobiotics to fight against resistance in the glycopeptide family. This study will eventually benefit thousands of people suffering in antibiotic-resistant and give them hope to survive!

–Vicky Gu